Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed May 17, 2022
- Accession no.
- 0001209191-22-029463
- Filed
- May 17, 2022, 6:33 AM ET
- Trade date
- May 16, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 9 non-derivative transactions. Open-market purchases total $446.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 16, 2022 | Common Stock | PPurchaseAcquired | +660 | $2.96 | +$1,950.3 | 195,757,354 | Indirect | |
| May 16, 2022 | Common Stock | PPurchaseAcquired | +18,282 | $2.96 | +$54,114.72 | 195,775,636 | Indirect | |
| May 16, 2022 | Common Stock | PPurchaseAcquired | +3,300 | $2.97 | +$9,784.5 | 195,778,936 | Indirect | |
| May 16, 2022 | Common Stock | PPurchaseAcquired | +11,358 | $2.97 | +$33,733.26 | 195,790,294 | Indirect | |
| May 16, 2022 | Common Stock | PPurchaseAcquired | +38,500 | $2.98 | +$114,537.5 | 195,828,794 | Indirect | |
| May 16, 2022 | Common Stock | PPurchaseAcquired | +4,100 | $2.98 | +$12,218 | 195,832,894 | Indirect | |
| May 16, 2022 | Common Stock | PPurchaseAcquired | +42,177 | $2.99 | +$125,898.35 | 195,875,071 | Indirect | |
| May 16, 2022 | Common Stock | PPurchaseAcquired | +30,723 | $2.99 | +$91,861.77 | 195,905,794 | Indirect | |
| May 16, 2022 | Common Stock | PPurchaseAcquired | +900 | $3.00 | +$2,695.5 | 195,906,694 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.